Back
Ocugen Vs. SpringWorks Therapeutics Industry Stock Comparison
Sell
28
OCGN
Ocugen
Last Price:
0.93
Seasonality Move:
37.88%
Sell
29
SWTX
SpringWorks Therapeutics
Last Price:
29.14
Seasonality Move:
39.52%
Sell
28
Ocugen (OCGN)
is a Sell
Is Ocugen a Buy, Sell or Hold?
- The current Ocugen [OCGN] share price is $0.93. The Score for OCGN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- OCGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
- The current SpringWorks Therapeutics [SWTX] share price is $29.80. The Score for SWTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCGN Stock Price Chart
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $29.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
OCGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 37.09 | Sell |
| Chaikin Money Flow: | 328188 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.94 - 1.06) | Sell |
| Bollinger Bands (100): | (1.06 - 1.62) | Sell |
SWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.48 | Sell |
| Relative Strength Index (14 RSI): | 32.12 | Sell |
| Chaikin Money Flow: | -483189 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.52 - 33.74) | Sell |
| Bollinger Bands (100): | (33.31 - 40.03) | Sell |
OCGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.95 | Sell |
| 20-day SMA: | 0.97 | Sell |
| 50-day SMA: | 1.12 | Sell |
| 200-day SMA: | 1.25 | Sell |
| 8-day EMA: | 0.95 | Sell |
| 20-day EMA: | 0.99 | Sell |
| 50-day EMA: | 1.11 | Sell |
| 200-day EMA: | 1.19 | Sell |
SWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.42 | Sell |
| 20-day SMA: | 31.49 | Sell |
| 50-day SMA: | 35.52 | Sell |
| 200-day SMA: | 41.09 | Sell |
| 8-day EMA: | 30.59 | Sell |
| 20-day EMA: | 31.83 | Sell |
| 50-day EMA: | 34.26 | Sell |
| 200-day EMA: | 37.1 | Sell |
Ocugen Earnings Growth & OCGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.06 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and an increase next year of $1.54 per share.
Ocugen Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SpringWorks Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||